English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/114277
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection

AuthorsGonzález-Moro, María B.; Reina, Ramsés ; García, Iker; Andrés, Sara; Glaria, Idoia ; Alzueta, María; Mora, María Isabel; Pérez de la Lastra, José María; Rodríguez, Dolores; Rodriguez, Juan Ramón; Esteban, Mariano ; Grilló, María Jesús ; Andrés, Damián F. de ; Amorena Zabalza, Beatriz
Issue Date29-Jul-2005
CitationVaccine 23: 4342-4352 (2005)
AbstractGene gun mucosal DNA immunization of sheep with a plasmid expressing the env gene of Maedi-Visna virus (MVV) was used to examine the protection against MVV infection in sheep from a naturally infected flock. For immunization, sheep were primed with a pcDNA plasmid (pcDNA-env) encoding the Env glycoproteins of MVV and boosted with combined pcDNA-env and pCR3.1-IFN-γ plasmid inoculations. The pcDNA plasmid used in the control group contained the lacZ coding sequences instead of the env gene. Within a month post-challenge, the viral load in the vaccinated group was lower (p≤0.05) and virus was only detected transiently compared with the control group. Furthermore, 2 months later, neutralizing antibodies (NtAb) were detected in all the control animals and none of the vaccinated animals (p≤0.01). These results demonstrated a significant early protective effect of this immunization strategy against MVV infection that restricts the virus replication following challenge in the absence of NtAb production. This vaccine protective effect against MVV infection disappeared after two years post-challenge, when active replication of MVV challenge strain was observed. Protection conferred by the vaccine could not be explained by OLA DRB1 allele or genotype differences. Most of the individuals were DRB1 heterozygous and none was totally resistant to infection. © 2005 Elsevier Ltd. All rights reserved.
DescriptionGonzález-Moro, María B. et al.
Publisher version (URL)http://dx.doi.org/10.1016/j.vaccine.2005.03.032
Identifiersdoi: 10.1016/j.vaccine.2005.03.032
issn: 0264-410X
Appears in Collections:(CNB) Artículos
(IDAB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.